aTyr Pharma, Inc. (ATYR) vs LianBio Sponsored ADR (LIANY)

aTyr Pharma, Inc. and LianBio Sponsored ADR are both Biotechnology companies. aTyr Pharma, Inc. and LianBio Sponsored ADR are of similar size ($34.2M and $31.4M). aTyr Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. Across the 12 metrics below, LianBio Sponsored ADR leads on 8 and aTyr Pharma, Inc. on 4.

Valuation

Metric ATYR LIANY Biotechnology median
P/E n/m 0.02 7.88
P/S 2.64 n/m 11.47
P/B 0.61 0.01 2.52
Price to free cash flow n/m 0.03 21.16
EV/EBITDA 0.42 5.71 0.74
EV/Sales (2.39) n/m 10.73
Earnings yield (206.67%) 4,811.17% (28.84%)
Free cash flow yield (186.29%) 3,996.57% (23.03%)

Profitability

Metric ATYR LIANY Biotechnology median
Gross margin 1.72% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) 70.96% (57.72%)
Return on assets (70.97%) 66.19% (49.22%)
Return on invested capital 0.00% (450.47%) 0.00%

Growth

Metric ATYR LIANY Biotechnology median
Revenue growth (TTM) 6.78% — 5.64%
EPS growth (last fiscal year) 6.98% 75.44% —
Revenue growth, 5-year CAGR (14.75%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR LIANY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.12 17.03 4.73
Net debt to EBITDA 1.01 7.41 0.96

Dividend

Metric ATYR LIANY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ATYR LIANY Biotechnology median
Market cap 31.38m 34.19m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack